Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Colorectal Neoplasms

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    January 2022
  1. ARCHAMBAULT AN, Jeon J, Lin Y, Thomas M, et al
    Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study.
    J Natl Cancer Inst. 2022 Jan 13. pii: 6506525. doi: 10.1093.
    PubMed     Abstract available


  2. SHANKARAN V, Unger JM, Darke AK, Suga JM, et al
    S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients.
    J Natl Cancer Inst. 2022 Jan 4. pii: 6492636. doi: 10.1093.
    PubMed     Abstract available


  3. GIOVANNUCCI E
    Molecular Biologic and Epidemiologic Insights for Preventability of Colorectal Cancer.
    J Natl Cancer Inst. 2022 Jan 3. pii: 6493343. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  4. WERNLY S, Datz C, Wernly B
    RE: Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals' Risk Profiles.
    J Natl Cancer Inst. 2021 Dec 25. pii: 6483088. doi: 10.1093.
    PubMed    


    October 2021
  5. LIPSYC-SHARF M, Zhang S, Ou FS, Ma C, et al
    Survival in Young-Onset Metastatic Colorectal Cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80405.
    J Natl Cancer Inst. 2021 Oct 12. pii: 6390822. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  6. FORMICA V, Sera F, Cremolini C, Riondino S, et al
    KRAS and BRAF Mutations in Stage II/III Colon Cancer: A Systematic Review and Meta-Analysis.
    J Natl Cancer Inst. 2021 Sep 20. pii: 6372696. doi: 10.1093.
    PubMed     Abstract available


  7. YIN J, Salem ME, Dixon JG, Jin Z, et al
    Re-Evaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials.
    J Natl Cancer Inst. 2021 Sep 10. pii: 6368068. doi: 10.1093.
    PubMed     Abstract available


  8. MORRIS JS
    Disease-Free Survival is a Promising Surrogate for Overall Survival in Colorectal Cancer Studies.
    J Natl Cancer Inst. 2021 Sep 10. pii: 6368067. doi: 10.1093.
    PubMed    


  9. LEE MS, Kopetz S
    Are Homologous Recombination Deficiency Mutations Relevant in Colorectal Cancer?
    J Natl Cancer Inst. 2021 Sep 1. pii: 6361597. doi: 10.1093.
    PubMed    


  10. MORETTO R, Elliott A, Zhang J, Arai H, et al
    Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications.
    J Natl Cancer Inst. 2021 Sep 1. pii: 6361603. doi: 10.1093.
    PubMed     Abstract available


  11. LU SSM, Mohammed Z, Haggstrom C, Myte R, et al
    Antibiotics Use and Subsequent Risk of Colorectal Cancer: A Swedish Nationwide Population-Based Study.
    J Natl Cancer Inst. 2021 Sep 1. pii: 6360113. doi: 10.1093.
    PubMed     Abstract available


  12. ZHANG J, Sears CL
    Antibiotic Use Impacts Colorectal Cancer: A Double-Edged Sword by Tumor Location?
    J Natl Cancer Inst. 2021 Sep 1. pii: 6360117. doi: 10.1093.
    PubMed    


    August 2021
  13. ENG C, Hochster H
    Early-Onset Colorectal Cancer: The Mystery Remains.
    J Natl Cancer Inst. 2021 Aug 18. pii: 6353734. doi: 10.1093.
    PubMed    


    July 2021
  14. UGAI T, Vayrynen JP, Haruki K, Akimoto N, et al
    Smoking and Incidence of Colorectal Cancer Subclassified by Tumor-Associated Macrophage Infiltrates.
    J Natl Cancer Inst. 2021 Jul 15. pii: 6321960. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  15. TEN HOORN S, de Back TR, Sommeijer DW, Vermeulen L, et al
    Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    J Natl Cancer Inst. 2021 Jun 2. pii: 6291249. doi: 10.1093.
    PubMed     Abstract available


  16. YIN J, Cohen R, Jin Z, Liu H, et al
    Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
    J Natl Cancer Inst. 2021 Jun 1. pii: 6290718. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  17. RANDON G, Yaeger R, Hechtman JF, Manca P, et al
    EGFR Amplification in Metastatic Colorectal Cancer.
    J Natl Cancer Inst. 2021 Apr 7. pii: 6213909. doi: 10.1093.
    PubMed     Abstract available


  18. WAGNER AD, Grothey A, Andre T, Dixon JG, et al
    Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database.
    J Natl Cancer Inst. 2021;113:400-407.
    PubMed     Abstract available


  19. ZAANAN A, Henriques J, Cohen R, Sefrioui D, et al
    Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial Origin.
    J Natl Cancer Inst. 2021;113:496-500.
    PubMed     Abstract available


    March 2021
  20. WANG K, Ma W, Wu K, Ogino S, et al
    Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals' Risk Profiles.
    J Natl Cancer Inst. 2021 Mar 18. pii: 6178004. doi: 10.1093.
    PubMed     Abstract available


  21. DEMB JB, Gupta S
    Realizing the Promise of Personalized Colorectal Cancer Screening in Practice.
    J Natl Cancer Inst. 2021 Mar 18. pii: 6178006. doi: 10.1093.
    PubMed    


  22. COHEN R, Liu H, Fiskum J, Adams R, et al
    BRAF V600E Mutation in First-line Metastatic Colorectal Cancer: an Analysis of Individual Patient Data from the ARCAD Database.
    J Natl Cancer Inst. 2021 Mar 18. pii: 6178005. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  23. MCNEIL JJ
    Aspirin and primary prevention of colorectal cancer: a still evolving story.
    J Natl Cancer Inst. 2021 Feb 2. pii: 6123750. doi: 10.1093.
    PubMed    


  24. ZHANG Y, Chan AT, Meyerhardt JA, Giovannucci EL, et al
    Timing of aspirin use in colorectal cancer chemoprevention: a prospective cohort study.
    J Natl Cancer Inst. 2021 Feb 2. pii: 6123749. doi: 10.1093.
    PubMed     Abstract available


  25. FIGUEIREDO JC, Jacobs EJ, Newton CC, Guinter MA, et al
    Associations of aspirin and non-aspirin non-steroidal anti-inflammatory drugs with colorectal cancer mortality after diagnosis.
    J Natl Cancer Inst. 2021 Feb 2. pii: 6123748. doi: 10.1093.
    PubMed     Abstract available


  26. RANSOHOFF DF
    Evaluating a New Cancer Screening Blood Test: Unintended Consequences and the Need for Clarity in Policy Making.
    J Natl Cancer Inst. 2021;113:109-111.
    PubMed    


    January 2021
  27. HOWREN A, Sayre EC, Loree JM, Gill S, et al
    Trends in the incidence of young-onset colorectal cancer with a focus on years approaching screening age: A population-based longitudinal study.
    J Natl Cancer Inst. 2021 Jan 25. pii: 6119347. doi: 10.1093.
    PubMed     Abstract available


  28. FEDEWA SA, Anderson JC, Siegel RL
    Colorectal Cancer incidence in Canada: what do rates at age 50 years reflect?
    J Natl Cancer Inst. 2021 Jan 25. pii: 6119348. doi: 10.1093.
    PubMed    


    December 2020
  29. JOSHI AD, Chan AT
    Racial differences in epigenetic aging of the colon: Implications for colorectal cancer.
    J Natl Cancer Inst. 2020 Dec 30. pii: 6055552. doi: 10.1093.
    PubMed    


    November 2020
  30. SNYDER RA, Hu CY, Zafar SN, Francescatti A, et al
    Racial Disparities in Recurrence and Overall Survival in Patients with Locoregional Colorectal Cancer.
    J Natl Cancer Inst. 2020 Nov 24. pii: 5999805. doi: 10.1093.
    PubMed     Abstract available


  31. MANZ CR, Schrag D
    Racial disparities in colorectal cancer recurrence and mortality: equitable care, inequitable outcomes?
    J Natl Cancer Inst. 2020 Nov 24. pii: 5999804. doi: 10.1093.
    PubMed    


  32. ZHENG X, Hur J, Nguyen LH, Liu J, et al
    Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer.
    J Natl Cancer Inst. 2020 Nov 2. pii: 5951179. doi: 10.1093.
    PubMed     Abstract available


  33. MURPHY N, Campbell PT, Gunter MJ
    Unravelling the etiology of early-onset colorectal cancer.
    J Natl Cancer Inst. 2020 Nov 2. pii: 5951177. doi: 10.1093.
    PubMed    


    September 2020
  34. ALDERSON PO, Summers RM
    The Evolving Status of Radiomics.
    J Natl Cancer Inst. 2020;112:869-870.
    PubMed    


    August 2020
  35. ROBERTS AW, Eiffert S, Wulff-Burchfield EM, Dusetzina SB, et al
    Opioid use disorder and overdose in older adults with breast, colorectal, or prostate cancer.
    J Natl Cancer Inst. 2020 Aug 17. pii: 5893484. doi: 10.1093.
    PubMed     Abstract available


  36. ROMESSER PB, Smith G, Crane CH
    Nonoperative Management of Rectal Cancer Shows Cost-Effectiveness, but Can Comparative Effectiveness Be Established?
    J Natl Cancer Inst. 2020;112:771-772.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: